Exozymes (EXOZ) Income towards Parent Company (2023 - 2026)

Exozymes (EXOZ) has reported Income towards Parent Company for 3 consecutive years, with -$2.8 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Income towards Parent Company fell 356.17% year-over-year to -$2.8 million; the TTM figure through Dec 2025 stood at -$9.3 million (down 100.07% YoY), while the FY2025 annual figure was -$9.2 million, down 97.79% from the prior year.
• Income towards Parent Company eased to -$2.8 million in Q4 2025 per EXOZ's latest filing, from -$2.3 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$520596.0 in Q3 2023 and bottomed at -$2.8 million in Q4 2025.
• Historically, Income towards Parent Company has averaged -$1.5 million across 3 years, with a median of -$1.5 million in 2024.
• Annual changes were most pronounced in 2024 — Income towards Parent Company soared 42.72% — and 2025, when it sank 356.17%.
• Exozymes' Income towards Parent Company stood at -$1.1 million in 2023, then surged by 42.72% to -$605094.0 in 2024, then plunged by 356.17% to -$2.8 million in 2025.
• Business Quant data shows EXOZ's Income towards Parent Company at -$2.8 million in Q4 2025, -$2.3 million in Q3 2025, and -$2.4 million in Q2 2025.